Add BrightSurf on Google Email

Science News Archive October 2010 - Page 18


Page 18 of 25

Cetuximab did not add significant benefit to NORDIC FLOX regimen in first line treatment of mCRC

Researchers reported that adding cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer did not improve response rates, progression-free survival, or overall survival. The NORDIC VII study included 566 patients and found no statistically significant differences between the treatment groups.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateOct 10, 2010

Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer

In a phase II study, patients with locally advanced and metastatic NSCLC experienced significant increases in survival time when treated with TTF therapy in combination with chemotherapy. The therapy has also been shown to have clinical efficacy in human trials for other solid tumors, including recurrent glioblastoma.

Struggling for breath

Researchers found that patients with pectus excavatum have reduced chest wall motion near the deformity and compensate by using abdominal muscles to draw in more air. The study suggests these patients may experience shortness of breath and easy fatigability due to the dysfunctional upper chest wall motion.

Prolonging first-line chemotherapy improves outcomes for patients with metastatic breast cancer

A new meta-analysis shows that continuing chemotherapy after bringing cancer under control can increase survival time and reduce disease progression in metastatic breast cancer patients. The analysis found a 34% reduction in disease progression and a 9% reduction in death rates for patients who received longer chemotherapy durations.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateOct 10, 2010

New definition of Alzheimer's disease could help select patients for trials of disease-modifying treatments

A new definition of Alzheimer's disease has been proposed to diagnose the condition earlier and select patients for trials of disease-modifying treatments. The revised definition includes biomarkers as a key diagnostic feature, enabling diagnosis at an earlier stage, and allows for more precise selection of patients for clinical trials.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateOct 10, 2010

Budget constraints limit FDA inspections

Research reveals that budgetary constraints have led to a less rigorous FDA inspection process, failing to provide necessary oversight and guidance to the pharmaceutical manufacturing industry. This can result in manufacturers taking advantage of the system and prioritizing complaints over addressing actual safety issues.

SourceInderscience Publishers·JournalInternational Journal of Business Continuity and Risk Management·DateOct 9, 2010

Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer

Erlotinib has been shown to improve progression-free survival in patients with advanced lung cancer carrying EGFR activating mutations. The OPTIMAL trial found that erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination. Safety analyses also showed lower rates of adverse events with erlotinib.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateOct 9, 2010

Health halos that make us fat

Researchers found that individuals who dine at establishments labeled as healthy tend to underestimate their actual caloric consumption and subsequently indulge in high-calorie treats. To combat this effect, experts suggest doubling estimated calorie counts for meals served at these restaurants.

SourceCornell Food & Brand Lab·JournalJournal of Consumer Research·DateOct 9, 2010

Investigational ovarian cancer drug shows promise against platinum resistant disease

A Phase II clinical trial of MLN8237, a selective Aurora A kinase inhibitor, demonstrates single-agent activity with durable disease control in some patients with ovarian cancer resistant to platinum-based chemotherapy. The study found encouraging responses in several patients, suggesting potential for future combination therapies.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateOct 9, 2010

Neurons cast votes to guide decision-making

Researchers found that certain neurons represent accumulation of evidence to a threshold and others represent evidence itself, driving decision-making. The study offers potential insights into psychological disorders, such as ADHD, where impairments in decision-making occur.

SourceVanderbilt University·JournalPsychological Review·DateOct 8, 2010

Taking a fresh look

A new study by Northwestern University researchers uses complex systems and computer modeling to better understand educational policies. The approach, which treats education as a complex system, has been applied to school choice and student tracking, revealing promising results in understanding policy implications.

SourceNorthwestern University·JournalScience·DateOct 8, 2010